412 related articles for article (PubMed ID: 29386164)
1. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release.
Al-Hanbali OA; Hamed R; Arafat M; Bakkour Y; Al-Matubsi H; Mansour R; Al-Bataineh Y; Aldhoun M; Sarfraz M; Dardas AKY
Pak J Pharm Sci; 2018 Jan; 31(1(Suppl.)):345-351. PubMed ID: 29386164
[TBL] [Abstract][Full Text] [Related]
2. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.
Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ
Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504
[TBL] [Abstract][Full Text] [Related]
3. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
4. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
Hamed R; Al Baraghthi T; Sunoqrot S
Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
[TBL] [Abstract][Full Text] [Related]
6. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
Khanvilkar KH; Huang Y; Moore AD
Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
[TBL] [Abstract][Full Text] [Related]
7. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
8. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
Park JB; Lim J; Kang CY; Lee BJ
Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
[TBL] [Abstract][Full Text] [Related]
9. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
Van Nguyen H; Nguyen VH; Lee BJ
Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
[TBL] [Abstract][Full Text] [Related]
10. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
Ravi PR; Ganga S; Saha RN
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
[TBL] [Abstract][Full Text] [Related]
11. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
[TBL] [Abstract][Full Text] [Related]
12. Application of simplex lattice design for the development of extended release tablets of model drug diclofenac sodium.
Phadke S; Kanekar T; Gumaste S; Parikh V
Ther Deliv; 2019 Aug; 10(8):515-525. PubMed ID: 31496380
[No Abstract] [Full Text] [Related]
13. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
Ferrero C; Massuelle D; Doelker E
J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices.
Ghori MU; Ginting G; Smith AM; Conway BR
Int J Pharm; 2014 Apr; 465(1-2):405-12. PubMed ID: 24560637
[TBL] [Abstract][Full Text] [Related]
15. Design and study of lamivudine oral controlled release tablets.
Ravi PR; Ganga S; Saha RN
AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
[TBL] [Abstract][Full Text] [Related]
16. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
Košir D; Vrečer F
Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
[TBL] [Abstract][Full Text] [Related]
17. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
Ali R; Dashevsky A; Bodmeier R
Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
[TBL] [Abstract][Full Text] [Related]
18. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
Bravo SA; Lamas MC; Salamón CJ
J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
[TBL] [Abstract][Full Text] [Related]
19. Extended release of flurbiprofen from tromethamine-buffered HPMC hydrophilic matrix tablets.
Pygall S; Kujawinski S; Timmins P; Melia C
Pharm Dev Technol; 2018 Nov; 23(9):874-881. PubMed ID: 28298171
[TBL] [Abstract][Full Text] [Related]
20. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
Hiremath PS; Saha RN
Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
